# Task Analysis and Strategy

## Initial Analysis of Data

The pool contains 33 molecules with 4 distinct scaffolds:

1. **Methoxybenzamide series** (`COc1ccc(cc1)C(=O)N-alkyl`): m05 (target), m15, m17, m22, m24, m28
2. **Nitrobenzamide series** (`O=[N+]([O-])c1ccc(cc1)C(=O)N-alkyl`): m02, m06, m09, m10, m12, m29, m31, m32, m33
3. **Biphenylamide series** (`c1ccc(cc1)-c1ccc(cc1)C(=O)N-alkyl`): m04, m08, m11, m13, m16, m20, m23, m26, m30
4. **Hydroxybenzamide series** (`OCC(O)C(O)C(O)C(=O)N-alkyl`): m01, m03, m07, m14, m18, m19, m21, m25, m27

## Target Molecule m05 Analysis
- SMILES: `COc1ccc(cc1)C(=O)NCCCCCCCCCCC`
- This is a methoxybenzamide with a 13-carbon alkyl chain (counting from N: 12 carbons in the chain after N)
- Pool contains shorter chain analogs: m15 (2C), m24 (3C), m28 (4C), m17 (5C), m22 (6C)
- m05 is the longest chain in this series in the pool

## Job 1 Strategy: Predicting QED for m05
1. Need to measure QED for methoxybenzamide series members to establish trend
2. Have 12 total measurements available (shared between Job 1 and Job 2)
3. Need to extrapolate beyond measured range (m05 has longer chain than any measured)
4. Should measure multiple points to establish trend shape

## Job 2 Strategy: Finding Backup Lead
Constraints:
1. Measured QED ≥ 0.6 (must measure)
2. psa ≥ 40 (check in data)
3. Not in same series as m05 (methoxybenzamide series)

Approach:
1. First filter by psa ≥ 40 (free)
2. Filter out methoxybenzamide series (free)
3. Then measure QED of promising candidates

## Initial Observations on psa Values
Looking at data:
- Methoxybenzamide series: all have psa = 38.33 (< 40)
- Nitrobenzamide series: all have psa = 72.24 (≥ 40)
- Biphenylamide series: all have psa = 29.1 (< 40)
- Hydroxybenzamide series: all have psa = 110.02 (≥ 40)

So for Job 2, viable candidates must come from nitrobenzamide or hydroxybenzamide series (psa ≥ 40).

## Job 1 Progress: Methoxybenzamide Series Measurements
Measured QED values for methoxybenzamide series:
- m15 (2C chain): QED = 0.7621
- m24 (3C chain): QED = 0.7919
- m28 (4C chain): QED = 0.7518
- m17 (5C chain): QED = 0.7498
- m22 (6C chain): QED = 0.7377

Chain length vs QED:
- 2C: 0.7621
- 3C: 0.7919 (peak)
- room4C: 0.7518
- 5C: 0.7498
- 6C: 0.7377

Trend: QED peaks at 3-carbon chain length, then decreases with longer chains. This suggests optimal drug-likeness at moderate chain length, with decreasing QED as hydrophobicity increases.

Target m05 has 13C chain (very long) - need to extrapolate this decreasing trend.

## Job 2 Progress: Finding Backup Lead
Measurement strategy:
- m19 (hydroxybenzamide, 5C chain): QED = 0.3244 (< 0.6)
- m12 (nitrobenzamide, 4C chain): QED = 0.4709 (< 0.6)
- m09 (nitrobenzamide, 2C chain): QED = 0.5826 (< 0.6)
- m02 (nitrobenzamide, 3C chain): QED = 0.6046 (≥ 0.6)

Found candidate: m02 satisfies all constraints:
1. Measured QED = 0.6046 ≥ 0.6 ✓
2. psa = 72.24 ≥ 40 ✓ (from data)
3. Not in methoxybenzamide series ✓ (nitrobenzamide series)

Remaining measurements: 3 (9 used so far)

## Additional Measurements for Trend Analysis
- m01 (hydroxybenzamide, 4C chain): QED = 0.3187 (< 0.6)
- m32 (nitrobenzamide, 5C chain): QED = 0.4683 (< 0.6)
- m33 (nitrobenzamide, 6C chain): QED = 0.4591 (< 0.6)

All 12 measurements used.

## Nitrobenzamide Series Trend Analysis
Chain length vs QED:
- n=2 (m09): 0.5826
- n=3 (m02): 0.6046 (peak)
- n=4 (m12): 0.4709
- n=5 (m32): 0.4683
- n=6 (m33): 0.4591

Similar pattern to methoxybenzamide: peak at moderate chain length (n=3), then decrease.

## m05 QED Prediction Analysis
For methoxybenzamide series:
Chain length (n = carbons in alkyl chain) vs QED:
- n=2 (m15): 0.7621
- n=3 (m24): 0.7919 (peak)
- n=4 (m28): 0.7518
- n=5 (m17): 0.7498
- n=6 (m22): 0.7377
- n=12 (m05): to predict

The decline from n=3 to n=6: Δ = 0.7919 - 0.7377 = 0.0542 over 3 carbons = 0.01807 per carbon on average.

If linear decline continues from n=6 to n=12 (6 more carbons): 0.7377 - (6 × 0.01807) = 0.7377 - 0.1084 = 0.6293

However, the decline appears to be slowing (largest drop from n=3 to n=4: 0.0401, then smaller drops). The decline might follow asymptotic exponential decay.

Looking at the pattern: after the initial drop, QED seems to stabilize around 0.74-0.75. The drop from n=5 to n=6 is only 0.0121. Extrapolating with diminishing returns suggests QED might approach ~0.65-0.68 range for n=12.

Given the data and trend, a reasonable prediction for m05 (n=12) is QED ≈ 0.65-0.68. I'll use 0.665 as my prediction.

## Final Predictions
1. m05 predicted QED: 0.665
   - Based on extrapolation of decreasing trend observed in methoxybenzamide series
   - Trend shows QED peaks at n=3 (0.7919), then declines gradually
   - At n=6, QED is 0.7377
   - Extrapolating to n=12 gives estimated QED ≈ 0.665

2. Backup lead compound: m02
   - Measured QED: 0.6046 (≥ 0.6)
   - psa: 72.24 (≥ 40)
   - Not in methoxybenzamide series (nitrobenzamide series)
   - Satisfies all three constraints

3. Congeneric series for m05: methoxybenzamide series includes m05, m15, m17, m22, m24, m28